| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/07/2009 | CA2704337A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 05/07/2009 | CA2704248A1 Calcium-rich alkaline powder produced from processed mollusc shells |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055305A1 External preparation comprising prostaglandin derivative |
| 05/06/2009 | EP2055300A2 Medicament comprising a C11-C21 alkanoic, alkenoic or alkynoic acid ester and a catechin |
| 05/06/2009 | EP2054078A2 Long-lasting absorption of flavonoids |
| 05/06/2009 | EP2054051A1 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis |
| 05/06/2009 | EP2054046A2 Compositions containing chalcones and use thereof |
| 05/06/2009 | EP2054020A1 Cosmetic composition comprising purine and/or a purine derivative and taurine |
| 05/06/2009 | EP1865957A4 Method of treating actinic keratosis |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1161248B1 Pharmaceutical composition containing nitrate source and an acidifying agent for treating open wound and burns |
| 05/06/2009 | CN101426934A Method of predicting skin spot formation and method of screening skin spot formation inhibitor with the use of spot site-increasing genes as indication |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426530A Wound healing polymer compositions and methods for use thereof |
| 05/06/2009 | CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101422597A Preparation method of trichomadesis-prevention hair-growth liquid |
| 05/06/2009 | CN101422583A Ointment for treating psoriasis and production method thereof |
| 05/06/2009 | CN101422578A Health-care preparation capable of removing the blood heat and stasis to remove acne and whiten and moisten the skin |
| 05/06/2009 | CN101422577A External traditional Chinese medicine for treating scald and burn and preparation method thereof |
| 05/06/2009 | CN101422567A Traditional Chinese medicine cosmetic body-building liquor |
| 05/06/2009 | CN101422566A Medical-herb stuffed pillow for treating leukotrichia and baldness and medicine liquor for treating baldness |
| 05/06/2009 | CN101422556A Exterior-applied medicine for treating dermatopathy |
| 05/06/2009 | CN101422554A Traditional Chinese medicine for treating acne |
| 05/06/2009 | CN101422551A Traditional Chinese medicine body scenting and building liquid |
| 05/06/2009 | CN101422543A Traditional Chinese medicine composition for treating psoriasis |
| 05/06/2009 | CN101422538A Medicine formula for treating vitiligo and preparation technique thereof |
| 05/06/2009 | CN101422528A Alopecia prevention composition and production method thereof |
| 05/06/2009 | CN101422509A Hair growth capsules |
| 05/06/2009 | CN101422488A Putrefaction-removing granulation-promoting paste |
| 05/06/2009 | CN101422484A Nano silver wound-protection anti-inflammation liquid and preparation method thereof |
| 05/06/2009 | CN101422474A Use of magnesium isoglycyrrhizinate preparation for vein in treating skin disease |
| 05/06/2009 | CN101422467A Immunosuppressant containing Withanolide type compound |
| 05/06/2009 | CN101422430A Ketoconazole m-thymol liquor for treating skin tinea |
| 05/06/2009 | CN101422427A Magnesium isoglycyrrhizinate cream and preparation method and use thereof |
| 05/06/2009 | CN101422425A Etretinate type medicine solid dispersion |
| 05/06/2009 | CN100484957C Thymosin beta4 derivative and its use |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484565C Compound skins lintement of Chinese medicine |
| 05/06/2009 | CN100484520C 5-aminoketone valerate externally-applied preparation and production thereof |
| 05/06/2009 | CN100484511C Blood-lucid ganoderma beautifying skin-care agent and its preparation |
| 05/05/2009 | US7528168 Administering 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester (Etomoxir) for therapy of psoriasis |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527811 Topical depigmenting formulations comprising an extract of Bellis perennis |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2265774C Antibacterial composition |
| 04/30/2009 | WO2009054992A1 Antimicrobial compositions comprising docusate |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054361A1 Hair growth promoter |
| 04/30/2009 | WO2009053934A2 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/30/2009 | WO2009053850A2 Herbal extracts for treatment of chronic wounds |
| 04/30/2009 | WO2009053594A2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment method |
| 04/30/2009 | WO2009053564A2 Cosmetic use of a lysate of bifidobacterium species for reinforcing the skin barrier function |
| 04/30/2009 | WO2009053439A2 An amorphous form of an anti-inflammatory compound |
| 04/30/2009 | WO2009030862A3 Use of travoprost for treating hair loss |
| 04/30/2009 | WO2009014624A3 Nrf2 inducers for treating epidermolysis bullosa simplex |
| 04/30/2009 | WO2007061942A3 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 04/30/2009 | US20090111891 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111890 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17, 18, 19, 20-tetranor PGF2 alpha ) cyclopropyl methyl amide |
| 04/30/2009 | US20090111889 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111883 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111882 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 04/30/2009 | US20090111881 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111880 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111875 Skin care compositions |
| 04/30/2009 | US20090111783 Dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin for treating the hyperpigmentation of pathological scars |
| 04/30/2009 | US20090111779 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 04/30/2009 | US20090111767 Modulation of insulin like growth factor i receptor expression |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111734 Compositions and methods for promoting hemostasis and other physiological activities |
| 04/30/2009 | US20090110738 Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110736 Alloplastic injectable dermal filler and methods of use thereof |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | US20090110733 Delivery means |
| 04/30/2009 | US20090110731 Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110730 Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110657 Skin care compositions |
| 04/30/2009 | US20090110649 Antipruritic cosmetic and dermatological preparations |
| 04/30/2009 | DE102008022102A1 Zusammensetzung zum Regulieren von Glucose im Blut und dazugehöriges Verfahren Composition for regulating glucose in the blood and associated method |
| 04/30/2009 | CA2703441A1 An amorphous form of an anti-inflammatory compound |
| 04/30/2009 | CA2700711A1 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP2052733A1 Herbal extracts for treatment of chronic wounds |
| 04/29/2009 | EP2052732A1 Antioxidant composition containing component originating in the bark of tree belonging to the genus acacia |
| 04/29/2009 | EP2052731A1 Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genusacacia |
| 04/29/2009 | EP2052714A1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP2051727A2 Methods for treating and limiting fibrotic disorders and keloids |
| 04/29/2009 | EP2051719A1 Preparation with marine collagens for protease inhibition |
| 04/29/2009 | EP2051718A2 Mesenchymal stem cells and uses therefor |
| 04/29/2009 | EP2051714A1 Drug combinations for the treatment of respiratory tract diseases |